Over a dozen publications from founder Dr. Andres Acosta, shows the improvement in weight loss for patients once classified by obesity phenotype. The knowledge gained through obesity phenotyping empowers physicians to treat individual patients using precision medicine.
The Obesity Journal recently published Dr. Acosta and team's pragmatic trial on obesity phenotyping and demonstrated a doubling of treatment responders, and twice as much weight loss for patients whose treatment is guided by their dominant obesity phenotype.